The Mission of the Manhattan Institute is
to develop and disseminate new ideas that
foster greater economic choice and
individual responsibility.

The Wall Street Journal Europe.

Courts Thin Out Lead Paint Lawsuits
September 19, 2007

By Jim Copland

This summer, government-sponsored lawsuits alleging that paint manufacturers created a “public nuisance” by making paint with lead pigment in or before 1978 met stinging courtroom defeats in major decisions by the Missouri, New Jersey and Ohio supreme courts, as well as a jury verdict in Wisconsin.

These adverse rulings marked a major reversal of fortune for the litigation industry, which viewed such suits as a potential heir to the litigation industry’s multibillion-dollar asbestos and tobacco business lines after a Rhode Island jury had ruled in 2006 that paint companies had to shoulder that state’s lead paint “abatement costs,” estimated to be as much as $3 billion.

While nominally filed on behalf of states and municipalities, the lead paint suits are the fruit of deals trial lawyers cut with government officials, who gave the private lawyers control of state litigation for a share of any proceeds. The lawyers’ strategy has mirrored what they used in extracting billions from the tobacco suits to recoup states’ health care expenses — unsurprisingly, since the lead paint litigation involves the same lawyers. ...

Enriching big political donors with the state’s multibillion-dollar contingency-fee litigation clearly has the potential for corruption. ...

But the problems with public lead paint litigation run far deeper. Although lead poisoning is undoubtedly harmful, lead paint litigation has been burgeoning even as the risk has been approaching the nonexistent. Lead paint has been banned since 1978, and paint companies voluntarily limited lead for indoor paint as early as 1955.

That fact, in addition to reductions of lead in drinking water and the elimination of leaded gasoline, has caused a sharp drop in lead-exposure levels. Only 1.6 percent of young children are today exposed to lead levels above the Centers for Disease Control’s current threshold, down from 7.6 percent in 1997 and a 98 percent reduction from the late 1970s. ...

Read the rest at: TrialLawyersInc.com

Jim Copland is a senior fellow at the Manhattan Institute.

©2007 Washington Examiner

 


Home | About MI | Scholars | Publications | Books | Links | Contact MI
City Journal | CAU | CCI | CEPE | CLP | CMP | CRD | ECNY
Thank you for visiting us.
To receive a General Information Packet, please email support@manhattan-institute.org
and include your name and address in your e-mail message.
Copyright © 2009 Manhattan Institute for Policy Research, Inc. All rights reserved.
52 Vanderbilt Avenue, New York, N.Y. 10017
phone (212) 599-7000 / fax (212) 599-3494